(Q48581285)

13 February 2018

title

Analysis of EGF+61A>G polymorphism and EGF serum levels in Brazilian glioma patients treated with perillyl alcohol-based therapy (English)

1 reference

13 February 2018

author name string

Francisco das Chagas Abreu da Silveira

1

1 reference

13 February 2018

Bruno de Almeida Lopes

2

1 reference

13 February 2018

Clovis Orlando da Fonseca

3

1 reference

13 February 2018

Thereza Quirico-Santos

4

1 reference

13 February 2018

Izabel Christina Nunes de Palmer Paixão

5

1 reference

13 February 2018

Lidia Maria da Fonte de Amorim

6

1 reference

13 February 2018

publication date

6 April 2012

1 reference

13 February 2018

Journal of Cancer Research and Clinical Oncology

published in

1 reference

13 February 2018

volume

138

1 reference

13 February 2018

issue

8

1 reference

13 February 2018

page(s)

1347-1354

1 reference

13 February 2018

Experimental approaches for the treatment of malignant gliomas

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1203-5

Association between epidermal growth factor +61 G/A polymorphism and glioma risk in a Chinese Han population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1203-5

A functional polymorphism in the EGF gene is found with increased frequency in glioblastoma multiforme patients and is associated with more aggressive disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1203-5

The phylogeography of Brazilian Y-chromosome lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1203-5

Diagnosis and treatment of recurrent high-grade astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1203-5

Perillyl alcohol attenuates Ras-ERK signaling to inhibit murine skin inflammation and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1203-5

Association between functional EGF+61 polymorphism and glioma risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1203-5

Preliminary results from a phase I/II study of perillyl alcohol intranasal administration in adults with recurrent malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1203-5

Efficacy of monoterpene perillyl alcohol upon survival rate of patients with recurrent glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1203-5

Prognostic effect of epidermal growth factor receptor and EGFRvIII in glioblastoma multiforme patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1203-5

Urinary epidermal growth factor in patients with gliomas: significance of the factor as a glial tumor marker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1203-5

MiR-146b-5p Suppresses EGFR Expression and ReducesIn VitroMigration and Invasion of Glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1203-5

A functional epidermal growth factor (EGF) polymorphism, EGF serum levels, and esophageal adenocarcinoma risk and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1203-5

Association between epidermal growth factor 61A/G polymorphism and hepatocellular carcinoma susceptibility in Chinese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1203-5

No association between EGF +61 A/G polymorphism and increased risk of glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1203-5

The 2007 WHO classification of tumours of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1203-5

Perillyl alcohol is an angiogenesis inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1203-5

A simple salting out procedure for extracting DNA from human nucleated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1203-5

Angiogenic factors as tumor markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1203-5

Genetic profile of astrocytic and oligodendroglial gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1203-5

Association study of an epidermal growth factor gene functional polymorphism with the risk and prognosis of gliomas in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1203-5

Association between +61G polymorphism of the EGF gene and glioma risk in different ethnicities: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1203-5

The 61 A/G EGF polymorphism is functional but is neither a prognostic marker nor a risk factor for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1203-5

Genetic polymorphism of epidermal growth factor 61A>G and cancer risk: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-012-1203-5

Vascularity and angiogenesis as predictors of growth in optic pathway/hypothalamic gliomas

21 January 2018

1 reference

12 December 2020

Modulation of Hepatic Gene Expression by Hepatocyte Nuclear Factor 1

1 reference

12 December 2020

Effect of epidermal growth factor on glioma cell growth, migration, and invasion in vitro.

1 reference

12 December 2020

Effects of perillyl alcohol in glial C6 cell line in vitro and anti-metastatic activity in chorioallantoic membrane model

1 reference

12 December 2020

EGF promoter SNPs, plasma EGF levels and risk of breast cancer in Chinese women

1 reference

12 December 2020

Association between functional polymorphism in EGF gene and malignant melanoma

1 reference

12 December 2020

Correlation of tumor topography and peritumoral edema of recurrent malignant gliomas with therapeutic response to intranasal administration of perillyl alcohol.

1 reference

12 December 2020

Association between EGF promoter polymorphisms and cancer risk: a meta-analysis

1 reference

12 December 2020

Chemo-Resistant Protein Expression Pattern of Glioblastoma Cells (A172) to Perillyl Alcohol

1 reference

12 December 2020

10.1007/S00432-012-1203-5

Identifiers

DOI

1 reference

13 February 2018

1 reference

13 February 2018